A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Part of paid clinical trials in Anchorage, Alaska.
- Sponsor
- Taiho Oncology, Inc.
- Study ID
- NCT07128199
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Adjuvant
- EGFR
- Early Stage Lung Cancer
- Exon 20
- Lung Cancer
- NSCLC, Early Stage
- Post-surgical
- Uncommon EGFR Mutations
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- TAS6417 — DRUGOral tablets.
- Zipalertinib Matching-placebo — DRUGOral tablets.
Study Details
The purpose of this study is to compare the efficacy of zipalertinib versus placebo in participants with early stage resected non-small cell lung cancer (NSCLC) harboring uncommon epidermal growth factor receptor mutation (EGFRmt).
Key Dates
- First listed
- Aug 17, 2025
- Start date
- Dec 22, 2025
- Status verified
- Oct 2026
- Primary completion
- Oct 1, 2029
- Completion
- Oct 1, 2032
Study Design
- Enrollment
- 360 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: ZipalertinibParticipants will receive zipalertinib orally until the participant meets any of the treatment discontinuation criteria.
- Placebo Comparator: PlaceboParticipants will receive zipalertinib matching-placebo, until the participant meets any of the treatment discontinuation criteria.
Primary Outcome Measure
Disease-free Survival (DFS) as Assessed by the Investigator [ Time Frame: Up to 5 years ]
Central Contacts
- Taiho Oncology, Inc.+1 844-878-2446
Locations (30)
Find similar trials in Anchorage, AK
By condition
By specialty
By research site
Alaska Oncology and Hematology· Anchorage, AKCity of Hope Comprehensive Cancer Center - Duarte· Duarte, CACity of Hope Comprehensive Cancer Center Orange County Lennar Foundation Cancer Center· Irvine, CAScripps Clinic Torrey Pines· La Jolla, CAKaiser Permanente - Vallejo Medical Center· Vallejo, CAGeorgetown University School of Medicine· Washington D.C., DC
Related Studies
- Lung Cancer Biomarkers and ScreeningRecruiting · NYU Langone Health · New York, New York
- Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung CancersRecruiting · Stanford University · Stanford, California
- Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung CancerRecruiting · University of California, Davis · Sacramento, California
- Molecular Analysis of Thoracic MalignanciesEnrolling By Invitation · Stanford University · Stanford, California